 | • レポートコード：MRC2Q12-19508 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、甲状腺ホルモンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 甲状腺ホルモンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 甲状腺ホルモンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 甲状腺ホルモンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの甲状腺ホルモンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の甲状腺ホルモンの売上および2028年までの予測に焦点を当てています。 甲状腺ホルモンのグローバル主要企業には、Abbott、Pfizer、Accord Healthcare、Acella Pharmaceuticals、Allergan Pharm、Alvogen、Amneal Pharmaceuticals、Athenex、Fresenius Kabi、IBSA Pharma、Lannett、Lupin Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 甲状腺ホルモン市場は、タイプとアプリケーションによって区分されます。世界の甲状腺ホルモン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 0.025mg、0.05mg、1mg、その他 【アプリケーション別セグメント】 病院、クリニック、薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 甲状腺ホルモン製品概要 - タイプ別市場（0.025mg、0.05mg、1mg、その他） - アプリケーション別市場（病院、クリニック、薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の甲状腺ホルモン販売量予測2017-2028 - 世界の甲状腺ホルモン売上予測2017-2028 - 甲状腺ホルモンの地域別販売量 - 甲状腺ホルモンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別甲状腺ホルモン販売量 - 主要メーカー別甲状腺ホルモン売上 - 主要メーカー別甲状腺ホルモン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（0.025mg、0.05mg、1mg、その他） - 甲状腺ホルモンのタイプ別販売量 - 甲状腺ホルモンのタイプ別売上 - 甲状腺ホルモンのタイプ別価格 ・アプリケーション別市場規模（病院、クリニック、薬局、その他） - 甲状腺ホルモンのアプリケーション別販売量 - 甲状腺ホルモンのアプリケーション別売上 - 甲状腺ホルモンのアプリケーション別価格 ・北米市場 - 北米の甲状腺ホルモン市場規模（タイプ別、アプリケーション別） - 主要国別の甲状腺ホルモン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの甲状腺ホルモン市場規模（タイプ別、アプリケーション別） - 主要国別の甲状腺ホルモン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の甲状腺ホルモン市場規模（タイプ別、アプリケーション別） - 主要国別の甲状腺ホルモン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の甲状腺ホルモン市場規模（タイプ別、アプリケーション別） - 主要国別の甲状腺ホルモン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの甲状腺ホルモン市場規模（タイプ別、アプリケーション別） - 主要国別の甲状腺ホルモン市場規模（トルコ、サウジアラビア） ・企業情報 Abbott、Pfizer、Accord Healthcare、Acella Pharmaceuticals、Allergan Pharm、Alvogen、Amneal Pharmaceuticals、Athenex、Fresenius Kabi、IBSA Pharma、Lannett、Lupin Pharmaceuticals ・産業チェーン及び販売チャネル分析 - 甲状腺ホルモンの産業チェーン分析 - 甲状腺ホルモンの原材料 - 甲状腺ホルモンの生産プロセス - 甲状腺ホルモンの販売及びマーケティング - 甲状腺ホルモンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 甲状腺ホルモンの産業動向 - 甲状腺ホルモンのマーケットドライバー - 甲状腺ホルモンの課題 - 甲状腺ホルモンの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Thyroid Hormones estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Thyroid Hormones is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Thyroid Hormones is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Thyroid Hormones is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Thyroid Hormones include Abbott, Pfizer, Accord Healthcare, Acella Pharmaceuticals, Allergan Pharm, Alvogen, Amneal Pharmaceuticals, Athenex and Fresenius Kabi, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Thyroid Hormones companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Thyroid Hormones market. Further, it explains the major drivers and regional dynamics of the global Thyroid Hormones market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Abbott
Pfizer
Accord Healthcare
Acella Pharmaceuticals
Allergan Pharm
Alvogen
Amneal Pharmaceuticals
Athenex
Fresenius Kabi
IBSA Pharma
Lannett
Lupin Pharmaceuticals
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Thyroid Hormones Segment by Type
0.025 mg
0.05 mg
1 mg
Others
Thyroid Hormones Segment by Application
Hospital
Clinics
Pharmacy
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Thyroid Hormones market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Thyroid Hormones market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Thyroid Hormones, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Thyroid Hormones, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Thyroid Hormones revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Thyroid Hormones market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Thyroid Hormones revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Pfizer, Accord Healthcare, Acella Pharmaceuticals, Allergan Pharm, Alvogen, Amneal Pharmaceuticals, Athenex and Fresenius Kabi, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Thyroid Hormones in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Thyroid Hormones companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Thyroid Hormones revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thyroid Hormones Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 0.025 mg
1.2.3 0.05 mg
1.2.4 1 mg
1.2.5 Others
1.3 Market by Application
1.3.1 Global Thyroid Hormones Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Thyroid Hormones Market Perspective (2017-2028)
2.2 Thyroid Hormones Growth Trends by Region
2.2.1 Thyroid Hormones Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Thyroid Hormones Historic Market Size by Region (2017-2022)
2.2.3 Thyroid Hormones Forecasted Market Size by Region (2023-2028)
2.3 Thyroid Hormones Market Dynamics
2.3.1 Thyroid Hormones Industry Trends
2.3.2 Thyroid Hormones Market Drivers
2.3.3 Thyroid Hormones Market Challenges
2.3.4 Thyroid Hormones Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Thyroid Hormones Players by Revenue
3.1.1 Global Top Thyroid Hormones Players by Revenue (2017-2022)
3.1.2 Global Thyroid Hormones Revenue Market Share by Players (2017-2022)
3.2 Global Thyroid Hormones Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Thyroid Hormones Revenue
3.4 Global Thyroid Hormones Market Concentration Ratio
3.4.1 Global Thyroid Hormones Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thyroid Hormones Revenue in 2021
3.5 Thyroid Hormones Key Players Head office and Area Served
3.6 Key Players Thyroid Hormones Product Solution and Service
3.7 Date of Enter into Thyroid Hormones Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Thyroid Hormones Breakdown Data by Type
4.1 Global Thyroid Hormones Historic Market Size by Type (2017-2022)
4.2 Global Thyroid Hormones Forecasted Market Size by Type (2023-2028)
5 Thyroid Hormones Breakdown Data by Application
5.1 Global Thyroid Hormones Historic Market Size by Application (2017-2022)
5.2 Global Thyroid Hormones Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Thyroid Hormones Market Size (2017-2028)
6.2 North America Thyroid Hormones Market Size by Type
6.2.1 North America Thyroid Hormones Market Size by Type (2017-2022)
6.2.2 North America Thyroid Hormones Market Size by Type (2023-2028)
6.2.3 North America Thyroid Hormones Market Share by Type (2017-2028)
6.3 North America Thyroid Hormones Market Size by Application
6.3.1 North America Thyroid Hormones Market Size by Application (2017-2022)
6.3.2 North America Thyroid Hormones Market Size by Application (2023-2028)
6.3.3 North America Thyroid Hormones Market Share by Application (2017-2028)
6.4 North America Thyroid Hormones Market Size by Country
6.4.1 North America Thyroid Hormones Market Size by Country (2017-2022)
6.4.2 North America Thyroid Hormones Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Thyroid Hormones Market Size (2017-2028)
7.2 Europe Thyroid Hormones Market Size by Type
7.2.1 Europe Thyroid Hormones Market Size by Type (2017-2022)
7.2.2 Europe Thyroid Hormones Market Size by Type (2023-2028)
7.2.3 Europe Thyroid Hormones Market Share by Type (2017-2028)
7.3 Europe Thyroid Hormones Market Size by Application
7.3.1 Europe Thyroid Hormones Market Size by Application (2017-2022)
7.3.2 Europe Thyroid Hormones Market Size by Application (2023-2028)
7.3.3 Europe Thyroid Hormones Market Share by Application (2017-2028)
7.4 Europe Thyroid Hormones Market Size by Country
7.4.1 Europe Thyroid Hormones Market Size by Country (2017-2022)
7.4.2 Europe Thyroid Hormones Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Thyroid Hormones Market Size (2017-2028)
8.2 Asia-Pacific Thyroid Hormones Market Size by Type
8.2.1 Asia-Pacific Thyroid Hormones Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Thyroid Hormones Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Thyroid Hormones Market Share by Type (2017-2028)
8.3 Asia-Pacific Thyroid Hormones Market Size by Application
8.3.1 Asia-Pacific Thyroid Hormones Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Thyroid Hormones Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Thyroid Hormones Market Share by Application (2017-2028)
8.4 Asia-Pacific Thyroid Hormones Market Size by Region
8.4.1 Asia-Pacific Thyroid Hormones Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Thyroid Hormones Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Thyroid Hormones Market Size (2017-2028)
9.2 Latin America Thyroid Hormones Market Size by Type
9.2.1 Latin America Thyroid Hormones Market Size by Type (2017-2022)
9.2.2 Latin America Thyroid Hormones Market Size by Type (2023-2028)
9.2.3 Latin America Thyroid Hormones Market Share by Type (2017-2028)
9.3 Latin America Thyroid Hormones Market Size by Application
9.3.1 Latin America Thyroid Hormones Market Size by Application (2017-2022)
9.3.2 Latin America Thyroid Hormones Market Size by Application (2023-2028)
9.3.3 Latin America Thyroid Hormones Market Share by Application (2017-2028)
9.4 Latin America Thyroid Hormones Market Size by Country
9.4.1 Latin America Thyroid Hormones Market Size by Country (2017-2022)
9.4.2 Latin America Thyroid Hormones Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Thyroid Hormones Market Size (2017-2028)
10.2 Middle East & Africa Thyroid Hormones Market Size by Type
10.2.1 Middle East & Africa Thyroid Hormones Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Thyroid Hormones Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Thyroid Hormones Market Share by Type (2017-2028)
10.3 Middle East & Africa Thyroid Hormones Market Size by Application
10.3.1 Middle East & Africa Thyroid Hormones Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Thyroid Hormones Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Thyroid Hormones Market Share by Application (2017-2028)
10.4 Middle East & Africa Thyroid Hormones Market Size by Country
10.4.1 Middle East & Africa Thyroid Hormones Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Thyroid Hormones Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Thyroid Hormones Introduction
11.1.4 Abbott Revenue in Thyroid Hormones Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Thyroid Hormones Introduction
11.2.4 Pfizer Revenue in Thyroid Hormones Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Accord Healthcare
11.3.1 Accord Healthcare Company Details
11.3.2 Accord Healthcare Business Overview
11.3.3 Accord Healthcare Thyroid Hormones Introduction
11.3.4 Accord Healthcare Revenue in Thyroid Hormones Business (2017-2022)
11.3.5 Accord Healthcare Recent Developments
11.4 Acella Pharmaceuticals
11.4.1 Acella Pharmaceuticals Company Details
11.4.2 Acella Pharmaceuticals Business Overview
11.4.3 Acella Pharmaceuticals Thyroid Hormones Introduction
11.4.4 Acella Pharmaceuticals Revenue in Thyroid Hormones Business (2017-2022)
11.4.5 Acella Pharmaceuticals Recent Developments
11.5 Allergan Pharm
11.5.1 Allergan Pharm Company Details
11.5.2 Allergan Pharm Business Overview
11.5.3 Allergan Pharm Thyroid Hormones Introduction
11.5.4 Allergan Pharm Revenue in Thyroid Hormones Business (2017-2022)
11.5.5 Allergan Pharm Recent Developments
11.6 Alvogen
11.6.1 Alvogen Company Details
11.6.2 Alvogen Business Overview
11.6.3 Alvogen Thyroid Hormones Introduction
11.6.4 Alvogen Revenue in Thyroid Hormones Business (2017-2022)
11.6.5 Alvogen Recent Developments
11.7 Amneal Pharmaceuticals
11.7.1 Amneal Pharmaceuticals Company Details
11.7.2 Amneal Pharmaceuticals Business Overview
11.7.3 Amneal Pharmaceuticals Thyroid Hormones Introduction
11.7.4 Amneal Pharmaceuticals Revenue in Thyroid Hormones Business (2017-2022)
11.7.5 Amneal Pharmaceuticals Recent Developments
11.8 Athenex
11.8.1 Athenex Company Details
11.8.2 Athenex Business Overview
11.8.3 Athenex Thyroid Hormones Introduction
11.8.4 Athenex Revenue in Thyroid Hormones Business (2017-2022)
11.8.5 Athenex Recent Developments
11.9 Fresenius Kabi
11.9.1 Fresenius Kabi Company Details
11.9.2 Fresenius Kabi Business Overview
11.9.3 Fresenius Kabi Thyroid Hormones Introduction
11.9.4 Fresenius Kabi Revenue in Thyroid Hormones Business (2017-2022)
11.9.5 Fresenius Kabi Recent Developments
11.10 IBSA Pharma
11.10.1 IBSA Pharma Company Details
11.10.2 IBSA Pharma Business Overview
11.10.3 IBSA Pharma Thyroid Hormones Introduction
11.10.4 IBSA Pharma Revenue in Thyroid Hormones Business (2017-2022)
11.10.5 IBSA Pharma Recent Developments
11.11 Lannett
11.11.1 Lannett Company Details
11.11.2 Lannett Business Overview
11.11.3 Lannett Thyroid Hormones Introduction
11.11.4 Lannett Revenue in Thyroid Hormones Business (2017-2022)
11.11.5 Lannett Recent Developments
11.12 Lupin Pharmaceuticals
11.12.1 Lupin Pharmaceuticals Company Details
11.12.2 Lupin Pharmaceuticals Business Overview
11.12.3 Lupin Pharmaceuticals Thyroid Hormones Introduction
11.12.4 Lupin Pharmaceuticals Revenue in Thyroid Hormones Business (2017-2022)
11.12.5 Lupin Pharmaceuticals Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer